Rational Design of Ligands with Optimized Residence Time

Area of Science:

• Pharmacology and Drug Design
• Computational Chemistry
• Molecular Biophysics

Background:

• Residence time (RT) is the duration a drug binds to its target, influencing efficacy and pharmacokinetics.
• Optimizing RT is vital for drug design, but structure-based design for desired RTs remains challenging.
• Current methods often focus on binding affinity, potentially overlooking the importance of sustained target engagement.

Purpose of the Study:

• To propose a combined computational approach for designing ligands with both high affinity and desired residence time.
• To address the limitations in structure-based ligand design concerning residence time optimization.
• To identify drug candidates that achieve full therapeutic action without adverse effects by modulating residence time.

Main Methods:

• Utilizing advanced molecular dynamics (MD) simulations to predict and analyze ligand-receptor interactions over time.
• Integrating classical computer-aided ligand design (CALD) techniques for structure-based optimization.
• Employing a multi-faceted computational strategy combining dynamic and static ligand-target interaction analyses.

Main Results:

• Demonstrated the feasibility of identifying ligands with specific residence time profiles.
• Showcased the synergy between molecular dynamics and computer-aided design in predicting ligand behavior.
• Provided a framework for selecting drug candidates with improved pharmacokinetic and efficacy profiles.

Conclusions:

• A combined molecular dynamics and computer-aided ligand design approach can effectively identify ligands with optimized residence time and high affinity.
• This strategy offers a promising pathway for structure-based drug design, moving beyond affinity alone.
• The proposed methods can lead to the development of safer and more effective therapeutics by ensuring appropriate target engagement duration.